La revue scientifique trimestrielle
Leveraging CHO cell potential in R&D and cGMP
With 25 years of experience handling hundreds of cell lines, Clean Cells is your reliable partner on both adherent and suspension models with cloning and manufacturing technologies for CHO cell lines. Our extensive portfolio of QC assays also ensures the best level of characterization for the most potent and safe CHO cells, with complementary and novel methods for monoclonal antibody characterization (ADCC).
Lire la suite
Clean Cells, your partner for single cell cloning to cGMP cell banks
As a contract organization specializing in cGMP cell & virus banking and QC testing, Clean Cells knows the importance of qualitative cell line development. We thus implemented Solentim’s VIPS® PRO, a state-of-the-art single cell cloning platform to isolate potent clones and characterize the monoclonality of biotherapeutics producing cell lines, with an increased traceability as part of a regulatory compliant approach.
Lire la suite
Increasing biologics manufacturing capacities
With 23+ years of experience handling hundreds of cell and virus models, Clean Cells has positioned itself as a leader in cell and virus banking, providing complementary characterization and storage services. Our state-of-the-art cGMP facility launched earlier this year now welcomes our biologics manufacturing capacities, providing 8 new clean rooms designed for all types of biopharma projects and equiped to meet production specifications for both adherent and suspension cells.
Lire la suite
Assessing the scale-X(TM) bioreactor’s biomanufacturing capacities on Vero cells
To further extend their biomanufacturing capabilities and cater to Univercells clients' growing needs, Naobios has recently conducted a comprehensive assessment of the performance of Vero cells cultured within the scale-X(TM) bioreactor provided by Univercells Technologies. This assessment aimed to evaluate the compatibility and efficiency of the Vero cell line in this novel bioreactor system for viral-based bioproduction.
Lire la suite
A new facility to extend biopharma services
Last January, Clean Cells opened its new cGMP-compliant facility, a cutting-edge 5 300 m2 platform which considerably extends biopharma capacities. Additional biologics testing capacity, extended cell and gene therapy services, end-to-end biomanufacturing and storage: Clean Cells’ new site opens a new chapter in the company’s rich history.
Lire la suite